Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function
Milad Rouhimoghadam, Anh S. Lu, Aliasger K. Salem, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Neurodegenerative Disease: Roles for Sex, Hormones, and Oxidative Stress
Nathalie Sumien, J. Thomas Cunningham, Delaney Davis, et al.
Endocrinology (2021) Vol. 162, Iss. 11
Open Access | Times Cited: 82
Breast Cancer MCF-7 Cell Spheroid Culture for Drug Discovery and Development
Guangping Chen, William Liu, Bingfang Yan
Journal of Cancer Therapy (2022) Vol. 13, Iss. 03, pp. 117-130
Open Access | Times Cited: 29
Toxicity overview of endocrine disrupting chemicals interacting in vitro with the oestrogen receptor
Raúl Alva-Gallegos, Alejandro Carazo, Přemysl Mladěnka
Environmental Toxicology and Pharmacology (2023) Vol. 99, pp. 104089-104089
Closed Access | Times Cited: 15
Overview of the therapeutic strategies for ER positive breast cancer
Brianna Blakely, Seobum Shin, Kideok Jin
Biochemical Pharmacology (2023) Vol. 212, pp. 115552-115552
Open Access | Times Cited: 14
The G Protein-Coupled Estrogen Receptor (GPER): A Critical Therapeutic Target for Cancer
Keith A. Hall, Edward J. Filardo
Cells (2023) Vol. 12, Iss. 20, pp. 2460-2460
Open Access | Times Cited: 14
Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers
Mirco Masi, Marco Racchi, Cristina Travelli, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2999-2999
Open Access | Times Cited: 28
G protein-coupled estrogen receptor stimulates human trophoblast cell invasion via YAP-mediated ANGPTL4 expression
Jung‐Chien Cheng, Lanlan Fang, Yuxi Li, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 28
Sex Differences in Colon Cancer: Genomic and Nongenomic Signalling of Oestrogen
Brian J. Harvey, Harry Harvey
Genes (2023) Vol. 14, Iss. 12, pp. 2225-2225
Open Access | Times Cited: 12
Interaction of GPER-1 with the endocrine signaling axis in breast cancer
Luis Molina Calistro, Yennyfer Arancibia, M. Olivera, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
From physiology to pathology: Emerging roles of GPER in cardiovascular disease
Zixuan Wang, Jiayong Liu, Ying Chen, et al.
Pharmacology & Therapeutics (2025), pp. 108801-108801
Closed Access
Skeletal muscle wasting: the estrogen side of sexual dimorphism
Shawna L. McMillin, Everett C. Minchew, Dawn A. Lowe, et al.
AJP Cell Physiology (2021) Vol. 322, Iss. 1, pp. C24-C37
Open Access | Times Cited: 26
Phytoestrogens, novel dietary supplements for breast cancer
Shuo Huang, Baowen Qi, Ling Yang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114341-114341
Open Access | Times Cited: 10
Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells
Francesca Cirillo, Asia Spinelli, Marianna Talia, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Genistein-Chitosan Derivative Nanoparticles for Targeting and Enhancing the Anti-Breast Cancer Effect of Tamoxifen In Vitro
Xing Yang, Weiguang Shen, Chuan Sun, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 8, pp. 2575-2583
Closed Access | Times Cited: 3
Advances in immune regulation of the G protein-coupled estrogen receptor
Hanzhi Dong, Xiaoqiang Zeng, Jiawei Xu, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112369-112369
Open Access | Times Cited: 3
Proteolytic Targeting Chimeras with Specificity for Plasma Membrane and Intracellular Estrogen Receptors
Anh S. Lu, Milad Rouhimoghadam, Christopher K. Arnatt, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 3, pp. 1455-1469
Open Access | Times Cited: 22
GPER: An Estrogen Receptor Key in Metastasis and Tumoral Microenvironments
Ana Carolina Tirado-Garibay, Elba Andrea Falcón-Ruiz, Alejandra Ochoa‐Zarzosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14993-14993
Open Access | Times Cited: 8
Targeting Estrogens and Various Estrogen-Related Receptors against Non-Small Cell Lung Cancers: A Perspective
Radhashree Maitra, Parth Malik, Tapan K. Mukherjee
Cancers (2021) Vol. 14, Iss. 1, pp. 80-80
Open Access | Times Cited: 17
GPER Agonist G-1 Disrupts Tubulin Dynamics and Potentiates Temozolomide to Impair Glioblastoma Cell Proliferation
Alex Hirtz, Nolwenn Lebourdais, Fabien Rech, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3438-3438
Open Access | Times Cited: 17
Pro-estrogenic and anti-inflammatory effects of Corchorus olitorius and Amaranthus hybridus leaves in DMBA-induced breast cancer
Omoremime Elizabeth Dania, Titilope M. Dokunmu, Bose E. Adegboye, et al.
Phytomedicine Plus (2024) Vol. 4, Iss. 2, pp. 100567-100567
Open Access | Times Cited: 2
Epimedin B exerts neuroprotective effect against MPTP-induced mouse model of Parkinson's disease: GPER as a potential target
Mei Zhang, Zifan Hu, Xiao‐Li Dong, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113955-113955
Open Access | Times Cited: 10
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer
Marilena Kampa, Rosamaria Lappano, Fedora Grande, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 653-653
Open Access | Times Cited: 6
Comparative G-Protein-Coupled Estrogen Receptor (GPER) Systems in Diabetic and Cancer Conditions: A Review
Aliyu Muhammad, Gilead Ebiegberi Forcados, Abdurrahman Pharmacy Yusuf, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8943-8943
Open Access | Times Cited: 9
Estrogen dysregulation, intraocular pressure, and glaucoma risk
Hannah Youngblood, Patricia V. Schoenlein, Louis R. Pasquale, et al.
Experimental Eye Research (2023) Vol. 237, pp. 109725-109725
Open Access | Times Cited: 5
Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells
Jin Hyung Kim, Seung‐Taek Lee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7521-7521
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top